Economy · News reference
Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool inflation fears.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Intel stock surged 4.03% to $101.05 on reports of potential manufacturing talks with SK Hynix to produce memory chips domestically in the U.S. for the first time. Multiple analyst target raises, including Melius Research's $165 price target and potential $200 upside in two years, also drove the gain. The deal could strengthen Intel's foundry business and attract high-profile customers amid growing AI demand.
Nvidia agreed to acquire Hugging Face for $11.9 billion ($12.9 billion including employee awards), a steep price at 86x annualized revenue. However, the acquisition gives Nvidia strategic access to a platform hosting 3 million models used by 18 million developers and 200,000+ companies. As AI chip competition intensifies from Meta, Microsoft, and others, Hugging Face provides Nvidia a way to remain relevant in the AI ecosystem beyond just selling GPUs. The key to success is maintaining the platform's openness across different hardware and frameworks to preserve developer loyalty.
AMD stock gains almost 4%. Discover key MACD momentum shifts, $530 resistance level, and Benzinga Edge ratings.
Super Micro Computer stock surges nearly 3% premarket as investors return to AI server hardware makers following an earlier sector-wide sell-off.
The global immunotherapy drugs market is experiencing significant growth driven by advances in biotechnology, rising demand for targeted treatments, and expanding therapeutic applications across cancer, autoimmune, and inflammatory diseases. Key growth factors include increasing disease burden, robust drug pipelines, personalized medicine adoption, and combination therapy development. The Americas and Europe remain dominant markets, while Asia-Pacific is emerging as a high-growth region. Major pharmaceutical and biotech companies are increasing R&D investments and collaboration to accelerate innovation.